Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.

System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum We randomly assigned 10 SNHs, identified patients with new stage 1 to stage 3 breast cancer, assessed ...

Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...

“Well, we don’t have as much evidence as we would like on steroid use during pregnancy,” the obstetrician warned my co-author, Natalia Emanuel, as she wrote a prescription for inhaled corticosteroids ...

Elemento is the director of the Englander Institute for Precision Medicine at Weill Cornell Medicine. Sternberg is the clinical director of the Englander Institute for Precision Medicine. Khozin is ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

In an effort to increase access to evidence-based interventions to help manage anxiety and depression, Mass General Brigham ...